Case number 2022-1208
H. Lundbeck A/S v. Lupin Ltd. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 16, 2024 | 9 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [976682] [22-1194, 22-1208, 22-1246] [MVH] [Entered: 01/16/2024 10:47 AM] (2) |
| Dec 7, 2023 | 7 | OPINION filed for the court by Dyk, Circuit Judge; Prost, Circuit Judge and Hughes, Circuit Judge. Precedential Opinion. Service as of this date by the Clerk of Court. [968399] [22-1194, 22-1208, 22-1246] [MVH] [Entered: 12/07/2023 10:31 AM] (23) |
| Dec 7, 2023 | 8 | JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: As directed in the opinion. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [968406] [22-1194, 22-1208, 22-1246] [MVH] [Entered: 12/07/2023 10:50 AM] (1) |
| Dec 21, 2021 | 6 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [5], Doc No. [4], Doc No. [3], ERROR: Documents filed in a member case. CORRECTION: Future documents should be filed in the lead appeal only 22-1194. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [820085] [JCW] [Entered: 12/21/2021 08:46 AM] (0) |
| Dec 20, 2021 | 3 | Entry of appearance for George F. Pappas; Einar Stole; Brianne Bharkhda; Kurt Calia as counsel for Appellees Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc. and H. Lundbeck A/S. Service: 12/20/2021 by email. [820046] [22-1208] [George Pappas] [Entered: 12/20/2021 06:09 PM] (2) |
| Dec 20, 2021 | 4 | Certificate of Interest for Appellees H. Lundbeck A/S, Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG and Takeda Pharmaceuticals U.S.A., Inc.. Service: 12/20/2021 by email. [820048] [22-1208] [George Pappas] [Entered: 12/20/2021 06:11 PM] (4) |
| Dec 20, 2021 | 5 | Docketing Statement for the Appellees H. Lundbeck A/S, Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG and Takeda Pharmaceuticals U.S.A., Inc.. Service: 12/20/2021 by email. [820050] [22-1208] [George Pappas] [Entered: 12/20/2021 06:12 PM] (2) |
| Dec 1, 2021 | 1 | Appeal docketed. Received: 11/29/2021. [815562]Entry of Appearance is due on 12/15/2021. Certificate of Interest is due on 12/15/2021. Docketing Statement is due on 12/15/2021. Appellants' brief is due on 01/31/2022. [JCW] [Entered: 12/01/2021 11:19 AM] (183) |
| Dec 1, 2021 | 2 | Note to File: The following cases are consolidated: 22-1194 Lead with 22-1208 Cross-Appeal. The parties must file all documents in the lead appeal only. [815566] [22-1194, 22-1208] [JCW] [Entered: 12/01/2021 11:23 AM] (0) |
